Mobile health applications for the management of primary hypertension: A multicenter, randomized, controlled trial
K Gong, YL Yan, Y Li, J Du, J Wang, Y Han, Y Zou… - Medicine, 2020 - journals.lww.com
… The purpose was to assess the impact of m… improve medication adherence. We analyzed
that the app could help control blood pressure mainly through improving medication adherence…
that the app could help control blood pressure mainly through improving medication adherence…
Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs
D Terentes-Printzios, N Ioakeimidis, K Rokkas… - Nature Reviews …, 2022 - nature.com
… The implications of a diagnosis of ED for the primary or secondary prevention of CVD … to
better compliance to cardiovascular therapy, prediction of cardiovascular events incrementally to …
better compliance to cardiovascular therapy, prediction of cardiovascular events incrementally to …
Access to cardiovascular disease and hypertension medicines in developing countries: an analysis of essential medicine lists, price, availability, and affordability
… cardiovascular disease and hypertension medicines to identify areas for improvement in
access to medication treatment… One of the compelling ways of illustrating the impact of medicine …
access to medication treatment… One of the compelling ways of illustrating the impact of medicine …
A policy prescription for reducing health disparities—achieving pharmacoequity
… development and clinical trial evaluation to prescription receipt and procurement of medications
from the local pharmacy. Achieving pharmacoequity must be a public health and policy …
from the local pharmacy. Achieving pharmacoequity must be a public health and policy …
Hypertension pharmacological treatment in adults: a World Health Organization guideline executive summary
A Al-Makki, D DiPette, PK Whelton, MH Murad… - …, 2022 - Am Heart Assoc
… Hypertension is a major cause of cardiovascular disease and … Clinical significance of
treatment-related adverse events … intensity of interventions that improve treatment adherence. …
treatment-related adverse events … intensity of interventions that improve treatment adherence. …
[HTML][HTML] … on top of maximally tolerated lipid‐modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of …
SJ Nicholls, AJ Nelson, M Ditmarsch, JJP Kastelein… - American Heart …, 2024 - Elsevier
… study drugs at visits 3 through 7 to allow research site staff to assess treatment adherence. At
… obicetrapib group compared to the placebo group at a one-sided significance level of 0.05. …
… obicetrapib group compared to the placebo group at a one-sided significance level of 0.05. …
Minimal-dose resistance training for improving muscle mass, strength, and function: a narrative review of current evidence and practical considerations
… For example, RT participation is associated with reduced all-cause and cancer-related
mortality and reduced incidence of cardiovascular disease, hypertension, and symptoms of both …
mortality and reduced incidence of cardiovascular disease, hypertension, and symptoms of both …
Positive airway pressure adherence, mortality, and cardiovascular events in patients with sleep apnea
C Gervès-Pinquié, S Bailly, F Goupil… - … Care Medicine, 2022 - atsjournals.org
… In real-life conditions, increasing PAP adherence is associated … , including CV active drug
adherence. The results highlight the … Although it did not reach statistical significance, our study …
adherence. The results highlight the … Although it did not reach statistical significance, our study …
Non-adherence to prescribed antihypertensives in primary, secondary and tertiary healthcare settings in Islamabad, Pakistan: a cross-sectional study
… Implications for Clinical Practice The findings of this study have critical implications for healthcare
practitioners and policy … the aim of improving medication adherence among patients. In …
practitioners and policy … the aim of improving medication adherence among patients. In …
Increasing Participation of Women in Cardiovascular Trials: JACC Council Perspectives
…, Cardiovascular Disease in Women Committee … - Journal of the American …, 2021 - jacc.org
… The striking lack of female representation at the clinical trial leadership level has implications
for women in academic medicine and for our female patients. Most major improvements in …
for women in academic medicine and for our female patients. Most major improvements in …